Compile Data Set for Download or QSAR
Report error Found 43 Enz. Inhib. hit(s) with all data for entry = 5851
TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97478(US8470816, 91)
Affinity DataIC50: 0.0920nMpH: 7.4Assay Description:IM-9 cells (2×10^5 cells/mL) were cultured for 3 days after inoculation, and centrifuged at 500×g for 10 min to give cell pellets. The ob...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97489(US8470816, 632)
Affinity DataIC50: 0.220nMpH: 7.5Assay Description:CHO cells expressing hNK2 receptor were cultured in a HAM-F12 medium containing 400 ug/mL geneticin, 100 U/mL penicillin, 100 ug/mL streptomycin and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97486(US8470816, 464)
Affinity DataIC50: 0.220nMpH: 7.5Assay Description:CHO cells expressing hNK2 receptor were cultured in a HAM-F12 medium containing 400 ug/mL geneticin, 100 U/mL penicillin, 100 ug/mL streptomycin and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97485(US8470816, 458)
Affinity DataIC50: 0.220nMpH: 7.5Assay Description:CHO cells expressing hNK2 receptor were cultured in a HAM-F12 medium containing 400 ug/mL geneticin, 100 U/mL penicillin, 100 ug/mL streptomycin and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97481(US8470816, 265)
Affinity DataIC50: 0.230nMpH: 7.5Assay Description:CHO cells expressing hNK2 receptor were cultured in a HAM-F12 medium containing 400 ug/mL geneticin, 100 U/mL penicillin, 100 ug/mL streptomycin and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97490(US8470816, 633)
Affinity DataIC50: 0.240nMpH: 7.5Assay Description:CHO cells expressing hNK2 receptor were cultured in a HAM-F12 medium containing 400 ug/mL geneticin, 100 U/mL penicillin, 100 ug/mL streptomycin and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97483(US8470816, 292)
Affinity DataIC50: 0.25nMpH: 7.5Assay Description:CHO cells expressing hNK2 receptor were cultured in a HAM-F12 medium containing 400 ug/mL geneticin, 100 U/mL penicillin, 100 ug/mL streptomycin and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97487(US8470816, 623)
Affinity DataIC50: 0.310nMpH: 7.5Assay Description:CHO cells expressing hNK2 receptor were cultured in a HAM-F12 medium containing 400 ug/mL geneticin, 100 U/mL penicillin, 100 ug/mL streptomycin and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97479(US8470816, 251a)
Affinity DataIC50: 0.310nMpH: 7.5Assay Description:CHO cells expressing hNK2 receptor were cultured in a HAM-F12 medium containing 400 ug/mL geneticin, 100 U/mL penicillin, 100 ug/mL streptomycin and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97491(US8470816, 635)
Affinity DataIC50: 0.360nMpH: 7.5Assay Description:CHO cells expressing hNK2 receptor were cultured in a HAM-F12 medium containing 400 ug/mL geneticin, 100 U/mL penicillin, 100 ug/mL streptomycin and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97482(US8470816, 268)
Affinity DataIC50: 0.420nMpH: 7.5Assay Description:CHO cells expressing hNK2 receptor were cultured in a HAM-F12 medium containing 400 ug/mL geneticin, 100 U/mL penicillin, 100 ug/mL streptomycin and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97472(US8470816, 18)
Affinity DataIC50: 0.450nMpH: 7.5Assay Description:CHO cells expressing hNK2 receptor were cultured in a HAM-F12 medium containing 400 ug/mL geneticin, 100 U/mL penicillin, 100 ug/mL streptomycin and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97488(US8470816, 629)
Affinity DataIC50: 0.550nMpH: 7.5Assay Description:CHO cells expressing hNK2 receptor were cultured in a HAM-F12 medium containing 400 ug/mL geneticin, 100 U/mL penicillin, 100 ug/mL streptomycin and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97480(US8470816, 252)
Affinity DataIC50: 0.560nMpH: 7.5Assay Description:CHO cells expressing hNK2 receptor were cultured in a HAM-F12 medium containing 400 ug/mL geneticin, 100 U/mL penicillin, 100 ug/mL streptomycin and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97478(US8470816, 91)
Affinity DataIC50: 0.790nMpH: 7.5Assay Description:CHO cells expressing hNK2 receptor were cultured in a HAM-F12 medium containing 400 ug/mL geneticin, 100 U/mL penicillin, 100 ug/mL streptomycin and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97484(US8470816, 318)
Affinity DataIC50: 0.820nMpH: 7.5Assay Description:CHO cells expressing hNK2 receptor were cultured in a HAM-F12 medium containing 400 ug/mL geneticin, 100 U/mL penicillin, 100 ug/mL streptomycin and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97475(US8470816, 30)
Affinity DataIC50: 1.10nMpH: 7.5Assay Description:CHO cells expressing hNK2 receptor were cultured in a HAM-F12 medium containing 400 ug/mL geneticin, 100 U/mL penicillin, 100 ug/mL streptomycin and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97477(US8470816, 82)
Affinity DataIC50: 1.5nMpH: 7.4Assay Description:IM-9 cells (2×10^5 cells/mL) were cultured for 3 days after inoculation, and centrifuged at 500×g for 10 min to give cell pellets. The ob...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97476(US8470816, 31)
Affinity DataIC50: 1.70nMpH: 7.5Assay Description:CHO cells expressing hNK2 receptor were cultured in a HAM-F12 medium containing 400 ug/mL geneticin, 100 U/mL penicillin, 100 ug/mL streptomycin and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97474(US8470816, 24)
Affinity DataIC50: 2nMpH: 7.5Assay Description:CHO cells expressing hNK2 receptor were cultured in a HAM-F12 medium containing 400 ug/mL geneticin, 100 U/mL penicillin, 100 ug/mL streptomycin and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97477(US8470816, 82)
Affinity DataIC50: 2.20nMpH: 7.5Assay Description:CHO cells expressing hNK2 receptor were cultured in a HAM-F12 medium containing 400 ug/mL geneticin, 100 U/mL penicillin, 100 ug/mL streptomycin and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97473(US8470816, 21)
Affinity DataIC50: 2.30nMpH: 7.5Assay Description:CHO cells expressing hNK2 receptor were cultured in a HAM-F12 medium containing 400 ug/mL geneticin, 100 U/mL penicillin, 100 ug/mL streptomycin and ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetTachykinin-3(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97475(US8470816, 30)
Affinity DataIC50: 23nMpH: 7.4Assay Description:CHO cells expressing hNK3 receptor were cultured in a MEMalpha medium (Nikken Seibutsu Igaku Kenkyusho, K.K.) containing 100 U/mL penicillin, 100 ug/...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetTachykinin-3(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97472(US8470816, 18)
Affinity DataIC50: 24nMpH: 7.4Assay Description:CHO cells expressing hNK3 receptor were cultured in a MEMalpha medium (Nikken Seibutsu Igaku Kenkyusho, K.K.) containing 100 U/mL penicillin, 100 ug/...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetTachykinin-3(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97474(US8470816, 24)
Affinity DataIC50: 49nMpH: 7.4Assay Description:CHO cells expressing hNK3 receptor were cultured in a MEMalpha medium (Nikken Seibutsu Igaku Kenkyusho, K.K.) containing 100 U/mL penicillin, 100 ug/...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97483(US8470816, 292)
Affinity DataIC50: 62nMpH: 7.4Assay Description:IM-9 cells (2×10^5 cells/mL) were cultured for 3 days after inoculation, and centrifuged at 500×g for 10 min to give cell pellets. The ob...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97472(US8470816, 18)
Affinity DataIC50: 67nMpH: 7.4Assay Description:IM-9 cells (2×10^5 cells/mL) were cultured for 3 days after inoculation, and centrifuged at 500×g for 10 min to give cell pellets. The ob...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97479(US8470816, 251a)
Affinity DataIC50: 78nMpH: 7.4Assay Description:IM-9 cells (2×10^5 cells/mL) were cultured for 3 days after inoculation, and centrifuged at 500×g for 10 min to give cell pellets. The ob...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97485(US8470816, 458)
Affinity DataIC50: 79nMpH: 7.4Assay Description:IM-9 cells (2×10^5 cells/mL) were cultured for 3 days after inoculation, and centrifuged at 500×g for 10 min to give cell pellets. The ob...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97481(US8470816, 265)
Affinity DataIC50: 80nMpH: 7.4Assay Description:IM-9 cells (2×10^5 cells/mL) were cultured for 3 days after inoculation, and centrifuged at 500×g for 10 min to give cell pellets. The ob...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97490(US8470816, 633)
Affinity DataIC50: 84nMpH: 7.4Assay Description:IM-9 cells (2×10^5 cells/mL) were cultured for 3 days after inoculation, and centrifuged at 500×g for 10 min to give cell pellets. The ob...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetTachykinin-3(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97473(US8470816, 21)
Affinity DataIC50: 130nMpH: 7.4Assay Description:CHO cells expressing hNK3 receptor were cultured in a MEMalpha medium (Nikken Seibutsu Igaku Kenkyusho, K.K.) containing 100 U/mL penicillin, 100 ug/...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97489(US8470816, 632)
Affinity DataIC50: 140nMpH: 7.4Assay Description:IM-9 cells (2×10^5 cells/mL) were cultured for 3 days after inoculation, and centrifuged at 500×g for 10 min to give cell pellets. The ob...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetTachykinin-3(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97476(US8470816, 31)
Affinity DataIC50: 160nMpH: 7.4Assay Description:CHO cells expressing hNK3 receptor were cultured in a MEMalpha medium (Nikken Seibutsu Igaku Kenkyusho, K.K.) containing 100 U/mL penicillin, 100 ug/...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97486(US8470816, 464)
Affinity DataIC50: 220nMpH: 7.4Assay Description:IM-9 cells (2×10^5 cells/mL) were cultured for 3 days after inoculation, and centrifuged at 500×g for 10 min to give cell pellets. The ob...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97475(US8470816, 30)
Affinity DataIC50: 240nMpH: 7.4Assay Description:IM-9 cells (2×10^5 cells/mL) were cultured for 3 days after inoculation, and centrifuged at 500×g for 10 min to give cell pellets. The ob...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97480(US8470816, 252)
Affinity DataIC50: 250nMpH: 7.4Assay Description:IM-9 cells (2×10^5 cells/mL) were cultured for 3 days after inoculation, and centrifuged at 500×g for 10 min to give cell pellets. The ob...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97474(US8470816, 24)
Affinity DataIC50: 260nMpH: 7.4Assay Description:IM-9 cells (2×10^5 cells/mL) were cultured for 3 days after inoculation, and centrifuged at 500×g for 10 min to give cell pellets. The ob...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetTachykinin-3(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97478(US8470816, 91)
Affinity DataIC50: 330nMpH: 7.4Assay Description:CHO cells expressing hNK3 receptor were cultured in a MEMalpha medium (Nikken Seibutsu Igaku Kenkyusho, K.K.) containing 100 U/mL penicillin, 100 ug/...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97473(US8470816, 21)
Affinity DataIC50: 330nMpH: 7.4Assay Description:IM-9 cells (2×10^5 cells/mL) were cultured for 3 days after inoculation, and centrifuged at 500×g for 10 min to give cell pellets. The ob...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97476(US8470816, 31)
Affinity DataIC50: 410nMpH: 7.4Assay Description:IM-9 cells (2×10^5 cells/mL) were cultured for 3 days after inoculation, and centrifuged at 500×g for 10 min to give cell pellets. The ob...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97484(US8470816, 318)
Affinity DataIC50: 520nMpH: 7.4Assay Description:IM-9 cells (2×10^5 cells/mL) were cultured for 3 days after inoculation, and centrifuged at 500×g for 10 min to give cell pellets. The ob...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97491(US8470816, 635)
Affinity DataIC50: 1.10E+3nMpH: 7.4Assay Description:IM-9 cells (2×10^5 cells/mL) were cultured for 3 days after inoculation, and centrifuged at 500×g for 10 min to give cell pellets. The ob...More data for this Ligand-Target Pair
In DepthDetails
US Patent